Adelphi Values has an experienced global team of qualitative researchers, health economists, statisticians, creative scientists, clinicians and strategists with industry experience, who truly understand the need to develop evidence and communicate value throughout the product lifecycle.
Below is a selection of our projects, presented according to therapeutic or strategic/methodological area. It is not exhaustive, and we would be happy to provide further information on request.
Manuscript on the understanding of payers and pricing in lupus nephritis
PRO consulting in lupus for labelling claims
Assessing utility for flares in systemic lupus erythematosus in the UK, France, Spain, Australia and Canada, including training and managing local interviewing agencies and providing support to local teams
Key opinion leader contracting and additional interviews for assessing utility in various severities of flares in systemic lupus erythematosus
Study on the treatment of systemic lupus erythematosus in Japan
Update of a literature search in systemic lupus erythematosus and lupus nephritis
Strategic literature review and gap analysis in systemic lupus erythematosus and lupus nephritis
Communication of a literature review on systemic lupus erythematosus and lupus nephritis
Indirect treatment comparison, network meta-analysis and feasibility assessment of therapies for lupus nephritis
Literature review and network meta-analysis feasibility assessment in lupus
Manuscript on the health-related quality of life benefits of a treatment for systemic lupus erythematosus
A study of the value of simple disease activity tools to rheumatologists who treat systemic lupus erythematosus
Target product profile development in systemic lupus erythematosus
Analysis of a PRO and resource utilisation in systemic lupus erythematosus
Development of posters on the analysis of a PRO and resource utilisation in systemic lupus erythematosus
Critical review of PRO instruments in systemic lupus erythematosus and fatigue and pain in rheumatic disease
Development of a budget impact model for primary mediastinal B-cell lymphoma (PMBCL)
Literature review and preparation of a PRO strategy in large B-cell lymphoma
Burden of diffuse large B-cell lymphoma on patients and caregivers
e-v@luate platform in diffuse large B-cell lymphoma
Hodgkin’s lymphoma
Payer evidence dossiers in non-Hodgkin’s lymphoma
Early payer engagement deck in classical Hodgkin’s lymphoma
Analyses of endpoints in oncology: Statistical analyses in Hodgkin’s lymphoma
Clinical trial analyses to support health-related quality of life in Hodgkin’s lymphoma
Non-Hodgkin’s lymphoma
Update of a payer evidence dossier in non-Hodgkin’s lymphoma
Literature review and conceptual mapping in non-Hodgkin’s lymphoma
Strategic PRO endpoint support, gap analysis and patient interviews in a biological therapy treatment for non-Hodgkin’s lymphoma
Validation of a patient satisfaction questionnaire in non-Hodgkin’s lymphoma
Conference poster and slide deck on non-Hodgkin’s lymphoma
Manuscript on a budget impact model for a cross-indication biosimilar in diffuse large B-Cell lymphoma, follicular lymphoma, follicular non-Hodgkin’s lymphoma
Lymphomas (other)
Core value dossier and value proposition in cutaneous T-cell lymphoma
Development of a budget impact tool for a treatment for chronic lymphatic lymphoma for Spain
Support programme for reimbursement submissions in cutaneous T-cell lymphoma
Strategic consulting for a lymphoma trial
Clinical trial analysis of health-related quality of life data in patients with previously untreated follicular lymphoma
Manuscript on a budget impact model for a cross-indication biosimilar in diffuse large B-Cell lymphoma, follicular lymphoma, and follicular non-Hodgkin’s lymphoma
Rapid payer research to inform investment decisions in diabetic macular edema
Cost-effectiveness model to inform investment decisions in diabetic macular edema
Mixed treatment comparison for treatment of patients with wet age-related macular degeneration
Burden of blindness study on inherited retinal degenerations
Survey protocol for a burden of blindness study
Development and validation of a screener and QoL module in macular degeneration
Burden of illness in wet age-related macular degeneration in Japan
Literature review of visual function literature to support the National Eye Institute Visual Function Questionnaire (NEI-VFQ) in age-related macular degeneration
Cross-sectional burden of illness study for age-related macular degeneration
FDA claim strategy and endpoint review of a visual function questionnaire in age-related macular degeneration and diabetic macular edema
Content validation of a visual function questionnaire in diabetic macular edema
Focus groups assessing patient experience with nasal spray in allergic rhinitis, analysis of results and development of a report on concept elicitation and cognitive debriefing
Validation of the preference module of the Experience with Allergic Rhinitis Nasal Spray Questionnaire (EARNS-Q)
Manuscript on the development of the EARNS-Q
Regulatory support for the EARNS-Q
Preference questionnaire on allergic rhinitis spray devices
Cardiovascular disease
Demonstrating the value of a transcatheter heart valve in aortic stenosis
Payer research on a device for symptomatic peripheral arterial disease
Gap analysis of PRO measures to substantiate labelling claims in angina trials of a drug-eluting stent (DES)
Development and validation of patient and clinician tools for myocardial infarction imaging
Analysis and reporting of myocardial infarction imaging validation study data
Clinician and patient satisfaction in an observational study in myocardial infarction SPECT imaging
Validation of clinician and patient questionnaires for myocardial infarction imaging
Demonstrating the value of a transcatheter heart valve in aortic stenosis
General consulting on a new stent device
Report on the cost of diagnosing vascular diseases with an MRA as the primary imaging modality
Central nervous system/neurology
Advisory board for a clinical screening tool for overactive bladder in multiple sclerosis (MS)
Development and validation of a clinical screening tool for overactive bladder in MS
Validation of a brief series of questions with a subgroup of MS patients
Dermatology
Testing PRO measures in electronic devices for rosacea
Endocrinology and metabolic diseases
Peripheral parenteral nutrition landscape review and manuscript for a medical device for surgical recovery
Development of a manuscript on patient perceptions of prefilled insulin delivery devices
Consultation on a market research study on patient perceptions of pre-filled insulin pens
Injection Pen Assessment Questionnaire (IPAQ) field study in growth hormone deficiency
Establishing support of content validity for the modified Injection Pen Assessment Questionnaire (IPAQ) in growth hormone deficiency
Development of an instrument to assess subject perception of two gastric bands in obesity
Gastrointestinal diseases
Development of a global value dossier and budget impact model for capsule endoscopy for colonoscopy
Global value dossier for a therapy device in refractory ascites
Translation to support development of a value dossier and budget impact model in capsule endoscopy for colonoscopy
Patient Assessment of Constipation Symptoms (PAC-SYM) and analysis of a skin patch containing an opioid pain medication
Managing patients with stoma: Adaptation of a Quality of Life Index (QLI) questionnaire to current needs for colostomy patients
Haematology
Development and testing of a novel web-based tool to evaluate patient preference for a reconstitution device for haemophilia A in a real-world setting
Immunology
Strategic consultancy on physician attitudes and preferences regarding adult vaccinations
Demonstrating the value of antibiotic resistance testing software
Measurement strategy to demonstrate efficacy of medical devices in patients with pigmented villonodular synovitis (PVNS) or tenosynovial giant cell tumour (dTGCT)
Infectious diseases
Systematic literature review on the indirect protection from the HPV vaccination
Value demonstration and implementation plan for a new HPV test
Value pack for a HPV vaccine
Training sales reps on an interactive model for a HPV vaccine
Update of a budget impact model for a HPV vaccine
Cost-effectiveness analysis of a HPV vaccine for Spain
HTA submission for a HPV vaccine
Manuscripts on the German and Spanish cost-effectiveness analysis of a HPV vaccine
Analysis and reporting on the budget impact of a HPV vaccine
Two manuscripts on an influenza vaccine for patients at risk and patients over 65 years old in France
Conference poster on the cost effectiveness of adjuvant influenza vaccination in France
Update of a value dossier on an influenza vaccine
Cost-effectiveness analysis of an influenza vaccine
Review of influenza vaccine uptake data
Updating an economic model of influenza vaccination (phase 1) – update of a model in patients aged over 65 years in France and the UK
Communications package for an influenza vaccine
Economic value dossiers for influenza vaccines in a) an unprimed paediatric population and b) a primed school age population (intranasal delivery) including literature review, gap analysis and recommendations
Economic evaluation of a workplace influenza vaccination in Russia
Communication of the economics of an influenza vaccine
Manuscripts on the health economics of a pneumococcal vaccine
Brief adaptation of a Markov model for a HPV vaccine
Adaptation of a Markov model on a HPV vaccine to Belgium
Development of a rationale for the need for a HPV vaccine
Communications package for an influenza vaccine
Adaptation of an influenza vaccine model to Belgium
Regulatory support for the validation of a questionnaire for influenza vaccination
Oncology
Cognitive debriefing interviews to assess usability of an ePRO device for use in forthcoming clinical trials in ovarian cancer
Ophthalmology
Formal recommendations on a regulatory briefing document for intraocular cataract lenses
Development of a PRO questionnaire to assess implantation of an intraocular lens in cataract patients
Cognitive interviews for the development of a PRO to assess intraocular lenses in cataract patients
Scientific dissemination of the patient-reported intraocular lens questionnaire
Etiology and meta-analysis of posterior cacular opacification comparing two lens types
Support on the intraocular cataract lenses (IOL) Expert Focus Group
Manuscript on HRQoL trial results of a new lens
Respiratory system
Global value dossier update and e-v@luate upload for an asthma device
Value proposition for a new metered dose inhaler to treat chronic obstructive pulmonary disease (COPD)
Structured literature review and qualitative interviews with payers/HCPs on a device for COPD
Development of a mini global value dossier for an asthma device
Structured literature reviews for paediatric wheeze detection
Rapid structured literature review of nebulisation inhalation efficiency in paediatric asthma and other respiratory conditions
Validation of the preference module of the Experience with Allergic Rhinitis Nasal Spray Questionnaire (EARNS-Q)
Manuscript on the development of the EARNS-Q
Focus groups assessing patient experience with nasal spray in allergic rhinitis, analysis of results and development of a report on concept elicitation and cognitive debriefing
Regulatory support for the EARNS-Q
Preference questionnaire on allergic rhinitis spray devices
Update to the pilot inference model for an inhaler used in the treatment of asthma
PRO strategy support for an inhaler treatment for COPD
Exit interviews on a connected inhaler system for asthma
Surgery and wound care
Training in a manual compression device for surgery
Strategic review of European market access potential for a surgical device
Value demonstration on a new wound care technology and the cost of pain management, allowing data to be tailored for local markets and local payers
AMCP dossiers for several surgical products
Identification of data inputs for a Canadian budget impact model in surgery
Urology and urogenital diseases
Systematic review of lithotripters for ureterolithiasis
Women’s health
Manuscript publication on a monthly contraceptive device
Modification, development and validation of an existing tool in order to explore satisfaction and tolerability for an intrauterine device (IUD) versus oral contraceptives
Modification of the EVAPIL-R in order to explore tolerability for an intrauterine system (IUS) versus an implantable contraceptive
Other
Value strategy training on access to medical devices
Panel and presentation on PRO research on medical devices
Adaptation of a multi-indication value-based pricing model in melanoma to China
Literature review in metastatic melanoma treatment patterns
Scientific communication of a systematic literature review on caregiver burden in advanced metastatic melanoma
Global value dossier for a treatment in melanoma
Development of global market access materials (disease burden slide deck, payer value story and FAQs) in metastatic melanoma to support local access teams
Payer slide decks and objection handler update in metastatic melanoma
Implementation guide in metastatic melanoma
Burden of disease deck update in ipi refractory and ipi naïve advanced melanoma
Payer value proposition deck update in ipi refractory advanced melanoma
Payer value proposition deck update in ipi naïve advanced melanoma
Updated implementation guide in melanoma
Frequently asked questions deck in ipi refractory and ipi naïve advanced melanoma
Updated burden of disease deck, payer value dossier decks and obstacle handler in a treatment for refractory & naïve melanoma
Development of a budget impact model for adjuvant melanoma
KOL interviews and primary research into treatment patterns in adjuvant melanoma
Payer value deck and response to payer questions in adjuvant melanoma
Payer value deck and response to payer questions update in advanced melanoma
Burden of disease deck in adjuvant melanoma
Burden of disease and payer value deck in adjuvant and advanced melanoma
Standardization of economic models in melanoma
Value-based model in melanoma
Multi-indication budget impact model in melanoma
Global model update and country adaptations for a multi-indication value-based pricing (VBP) model on melanoma
Adaptation of a value-based pricing multi-indication global model in oncology to Greece
Strategic communications planning in melanoma
Update to a Belgian value-based pricing model in melanoma
Updates to a Health Impact Projection (HIP) model in adjuvant melanoma and unresectable or metastatic melanoma
Preparation of a genomics methods paper in melanoma
Summary presentation of a workstream in melanoma
Caregiver burden in advanced melanoma
Caregiver burden in melanoma in the EU
Evidence synthesis on the comparative effectiveness of systemic therapies for unresectable stage IIIc and stage IV melanoma
Pilot patient interviews in melanoma
Exploratory analyses of endpoints in oncology: Statistical analyses in melanoma
Analyses of endpoints in oncology: Statistical analyses in first-line melanoma
Clinical trial analyses to support the relationship between adverse events and health-related quality of life, health status and work productivity in melanoma
Clinical trial analyses to support health-related quality of life in melanoma: AMNOG analyses for combination arm therapy
Network meta-analysis on the efficacy of first line treatment for unresectable stage IIIC/IV melanoma
AMNOG analyses to support health-related quality of life in melanoma
Cost utility analysis of hormone replacement therapy (HRT)
Observational study of HRT
Cognitive debriefing of a women’s health screening tool
Consultancy on FDA documents on the menopause
Psychometric validation of the SAM/WSM using PNS validation study data
Literature review of HRT outcomes in the menopause
Development of a conceptual model for vasomotor symptoms in post-menopausal women
Trial of two drugs used to treat menopausal symptoms
Pilot testing of a paper hot flash diary and questionnaire on the menopause
Development of a PRO instrument for measuring mood swings and sleep problems resulting from vasomotor symptoms during the menopause
Development of a briefing document for measuring the impact of menopausal hot flushes
Development of a PRO for breast pain/pressure and vaginal bleeding/spotting for female patients on HRT
Manuscript reporting results of qualitative work to support development of a breast pain daily diary (BP-DD) and vaginal bleeding/spotting daily diary (VBS-DD)
Understanding the experience of the mucopolysaccharidosis I (MPS I) patient to improve outcome assessments: evidence from the literature and treatment experts
Cognitive debriefing interviews on the Mucopolysaccharidosis Health Assessment Questionnaire (MPS-HAQ)
Evaluating the MPS-HAQ for use in patient registries to support EMA regulatory commitments
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsRead MoreACCEPTREJECT
Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
We’d like to set analytic software i.e. Google Analytics/Click Dimensions to help us improve our website by collecting and reporting information on how you use it. The cookies collect information in a way that does not directly identify anyone. For more information on how these cookies work, please see our Cookies Policy.